Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-09-27 to 2024-10-21
Current total value of award: $52912.4
Description: 4566008035!TYSABRI 300 MG/15 ML VIAL 15ML